El farmacéutico, garante de la salud del paciente en la dispensación de ácido acetilsalicílico 500 mg

Introducción: La dispensación de medicamentos en España es responsabilidad del farmacéutico. En el caso de los medicamentos no sujetos a prescripción médica (MSP) es el farmacéutico el que asegura su buen uso y puede evitar la aparición de RAM. Uno de los MSP más conocidos es la Aspirina®, 500 mg de ácido acetilsalicílico (AAS). Este estudio pretende analizar las intervenciones farmacéuticas que se llevan a cabo al dispensar MSP con 500 mg de AAS.Material y métodos: 18 farmacias comunitarias participaron en este estudio observacional prospectivo. Desde junio de 2013 a junio de 2014 se documentaron todas las intervenciones realizadas a los pacientes que demandaron MSP con 500 mg de AAS y que estuvieran en alguna de las situaciones de riesgo para el consumo de estos medicamentos.Resultados: De las 3.355 demandas de MSP con 500 mg de AAS contabilizadas, los farmacéuticos intervinieron en 182 ocasiones (el 5,4% de las veces). Un 20% de las intervenciones estaban relacionadas con el tiempo de duración del tratamiento, un 24% con patologías en las que el uso de AAS está contraindicado, otro 24% con la alteración de pruebas analíticas y un 26% con la interacción con otros medicamentos.Discusión: El 5,4% de las veces que se demandó un MSP con 500 mg de AAS, la intervención del farmacéutico pudo evitar una RAM. Esto hace pensar si es apropiado el plantear que el ASS salga de la farmacia comunitaria. Planteamiento corroborado por el menor número de comunicaciones de RAM relacionadas con AAS de España en relación con el resto de Europa

Temperature-Dependent Anisotropic Refractive Index in β-Ga2O3: Application in Interferometric Thermometers

An accurate knowledge of the optical properties of β-Ga2O3 is key to developing the full potential of this oxide for photonics applications. In particular, the dependence of these properties on temperature is still being studied. Optical micro- and nanocavities are promising for a wide range of applications. They can be created within microwires and nanowires via distributed Bragg reflectors (DBR), i.e., periodic patterns of the refractive index in dielectric materials, acting as tunable mirrors. In this work, the effect of temperature on the anisotropic refractive index of β-Ga2O3 n(λ,T) was analyzed with ellipsometry in a bulk crystal, and temperature-dependent dispersion relations were obtained, with them being fitted to Sellmeier formalism in the visible range. Micro-photoluminescence (μ-PL) spectroscopy of microcavities that developed within Cr-doped β-Ga2O3 nanowires shows the characteristic thermal shift of red–infrared Fabry–Perot optical resonances when excited with different laser powers. The origin of this shift is mainly related to the variation in the temperature of the refractive index. A comparison of these two experimental results was performed by finite-difference time-domain (FDTD) simulations, considering the exact morphology of the wires and the temperature-dependent, anisotropic refractive index. The shifts caused by temperature variations observed by μ-PL are similar, though slightly larger than those obtained with FDTD when implementing the n(λ,T) obtained with ellipsometry. The thermo-optic coefficient was calculated.This work was supported by MICINN projects (RTI2018-097195-B-I00, RTI2018-096918-B-C41, PID2021-122562NB-I00 and PID2021-123190OB-I00/AEI/10.13039/501100011033/FEDER, UE). The authors acknowledge the financial support of the excellence research network RED2018-102609-T by MINECO. The authors acknowledge the support from the Air Force Office of Scientific Research under Award No. FA8655-20-1-7013 (Program Manager: Ali Sayir). M.A.-O. acknowledges financial support from MICINN (FPU contract No. FPU15/01982) and thanks the Central Research Development Fund (CRDF) of the University of Bremen for funding (ZF04/2021). J.S.M. and J.J. were supported by the Air Force Office of Scientific Research under award number FA9550–21–1–0507, monitored by Dr. Ali Sayir. Any opinions, finding, and conclusions or recommendations expressed in this material are those of the author and do not necessarily reflect the views of the United States Air Force

Marco activo de recursos de innovación docente: Madrid

Una guía de espacios e instituciones para actividades educativas complementarias en enseñanza secundaria y Formación Profesional

Propuesta de coordinación horizontal y vertical en el Máster en Profesor de Secundaria

Memoria ID-0191. Ayudas de la Universidad de Salamanca para la innovación docente, curso 2015-2016

Aula virtual de Máster en Profesor de Secundaria

Memoria ID-0322. Ayudas de la Universidad de Salamanca para la innovación docente, curso 2014-2015

Correction : Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study. J. Clin. Med. 2021, 10, 2885

The authors wish to make the following corrections to this paper [...]

Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain : Large-Scale Epidemiological Study

(1) Aims: To assess the incidence of inflammatory bowel disease (IBD) in Spain, to describe the main epidemiological and clinical characteristics at diagnosis and the evolution of the disease, and to explore the use of drug treatments. (2) Methods: Prospective, population-based nationwide registry. Adult patients diagnosed with IBD-Crohn's disease (CD), ulcerative colitis (UC) or IBD unclassified (IBD-U)-during 2017 in Spain were included and were followed-up for 1 year. (3) Results: We identified 3611 incident cases of IBD diagnosed during 2017 in 108 hospitals covering over 22 million inhabitants. The overall incidence (cases/100,000 person-years) was 16 for IBD, 7.5 for CD, 8 for UC, and 0.5 for IBD-U; 53% of patients were male and median age was 43 years (interquartile range = 31-56 years). During a median 12-month follow-up, 34% of patients were treated with systemic steroids, 25% with immunomodulators, 15% with biologics and 5.6% underwent surgery. The percentage of patients under these treatments was significantly higher in CD than UC and IBD-U. Use of systemic steroids and biologics was significantly higher in hospitals with high resources. In total, 28% of patients were hospitalized (35% CD and 22% UC patients, p < 0.01). (4) Conclusion: The incidence of IBD in Spain is rather high and similar to that reported in Northern Europe. IBD patients require substantial therapeutic resources, which are greater in CD and in hospitals with high resources, and much higher than previously reported. One third of patients are hospitalized in the first year after diagnosis and a relevant proportion undergo surgery

GEODIVULGAR: Geología y Sociedad

Fac. de Ciencias GeológicasFALSEsubmitte

Clonal chromosomal mosaicism and loss of chromosome Y in elderly men increase vulnerability for SARS-CoV-2

The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID-19) had an estimated overall case fatality ratio of 1.38% (pre-vaccination), being 53% higher in males and increasing exponentially with age. Among 9578 individuals diagnosed with COVID-19 in the SCOURGE study, we found 133 cases (1.42%) with detectable clonal mosaicism for chromosome alterations (mCA) and 226 males (5.08%) with acquired loss of chromosome Y (LOY). Individuals with clonal mosaic events (mCA and/or LOY) showed a 54% increase in the risk of COVID-19 lethality. LOY is associated with transcriptomic biomarkers of immune dysfunction, pro-coagulation activity and cardiovascular risk. Interferon-induced genes involved in the initial immune response to SARS-CoV-2 are also down-regulated in LOY. Thus, mCA and LOY underlie at least part of the sex-biased severity and mortality of COVID-19 in aging patients. Given its potential therapeutic and prognostic relevance, evaluation of clonal mosaicism should be implemented as biomarker of COVID-19 severity in elderly people. Among 9578 individuals diagnosed with COVID-19 in the SCOURGE study, individuals with clonal mosaic events (clonal mosaicism for chromosome alterations and/or loss of chromosome Y) showed an increased risk of COVID-19 lethality